Topic · page 2 of 12

Across rheumatic diseases

Only studies that genuinely span several rheumatic diseases, such as drug safety and pharmacovigilance, infection, vaccination and comorbidity (cardiovascular, cancer, mental health) across diseases, and health services and quality of care across diseases. Never a fallback for an article that is hard to place

Briefs 41–80 of 474 placed here, newest publication first

Briefs in Across rheumatic diseases

Newest publication first

Rheumatology (Oxford)26 Jun 2026
Loneliness, traditional risk factor control, genetic predisposition, and development of musculoskeletal disorders
Cohort study
Joint Bone Spine23 Jun 2026
Evaluating the impact of a rheumatologist-led comorbidity review in patients with inflammatory arthritis
Cohort study
Ann Rheum Dis22 Jun 2026
Referral pathways and duration of care for musculoskeletal complaints across Europe: an analysis of primary and secondary care
Cohort study
Semin Arthritis Rheum19 Jun 2026
Development of a single‑item patient‑reported measure of treatment side‑effect burden in clinical trials of rheumatic and musculoskeletal diseases using stakeholder input and large language model refinement
Guideline or statement
RMD Open16 Jun 2026
Carotid-femoral pulse wave velocity improves cardiovascular risk prediction beyond SCORE2 in autoimmune rheumatic diseases: a 7-year follow-up study
Cohort study
Arthritis Care Res (Hoboken)10 Jun 2026
Perceived Impacts and Predictors of Cannabis Products Used by Patients with Rheumatologic Conditions in Alberta, Canada: A Multivariable Analysis of Cross‐Sectional Survey Data
Cross-sectional study
Semin Arthritis Rheum3 Jun 2026
Perioperative management of biologic disease-modifying antirheumatic drugs in patients with inflammatory rheumatic diseases undergoing total joint arthroplasty: A nationwide population-based cohort study from Taiwan
Cohort study
Ann Rheum Dis31 May 2026
Integrated transcriptomic and epigenomic profiling reveals conserved molecular subtypes across systemic autoimmune diseases
Cross-sectional study
Ann Rheum Dis29 May 2026
Global and high-income regional burden and healthcare costs of musculoskeletal diseases, 1990-2023
Research article
Arthritis Rheumatol18 May 2026
The American College of Rheumatology Updated Recommended Methods for Development of Disease Classification and Response Criteria
Guideline or statement
RMD Open11 May 2026
Trends in prevalence and disability burden of main rheumatic and musculoskeletal diseases in France 2008–2022
Cross-sectional study
Arthritis Care Res (Hoboken)10 May 2026
Formal and Informal Social Care in People With Rheumatic and Musculoskeletal Diseases: A Cross‐Sectional Multicenter Survey
Cross-sectional study
Semin Arthritis Rheum9 May 2026
Large language models in rheumatology-centered research: A scoping review of model openness and reporting practices
Research article
Rheumatology (Oxford)5 May 2026
Risk of interstitial lung disease following COVID-19 infection in patients with autoimmune diseases: a retrospective cohort study
Cohort study
Ann Rheum Dis30 Apr 2026
Efficacy and safety of nerandomilast in patients with autoimmune disease-related progressive pulmonary fibrosis in the FIBRONEER-ILD trial
Secondary analysis
Arthritis Rheumatol27 Apr 2026
Differences in SARS ‐ CoV ‐2 Antigen Persistence in Individuals With Systemic Autoimmune Rheumatic Diseases Compared to the General Population: A RECOVER ‐Adult Cohort Study
Cohort study
Clin Exp Rheumatol25 Apr 2026
Pneumocystis jirovecii pneumonia prophylaxis in rare systemic autoimmune rheumatic diseases: a systematic review of randomised controlled trials within the European Reference Network on Connective Tissue and Musculoskeletal Diseases
Meta-analysis
Arthritis Rheumatol22 Apr 2026
Immune Complexes Shape the Pathogenicity of Autoantibodies in Systemic Autoimmune Diseases: Insights From an FcγRIIIA ‐Reporter Assay
Cross-sectional study
Arthritis Rheumatol20 Apr 2026
Validation of International Classification of Diseases Code–Based Case Definitions of Immune Checkpoint Inhibitor–Associated Inflammatory Arthritis From Administrative Health Data
Diagnostic or prognostic study
Arthritis Res Ther16 Apr 2026
Development and preliminary evaluation of a measure ofself-efficacy of Self-Management in ARThritis: SMART
Secondary analysis
Ann Rheum Dis10 Apr 2026
Oral glucocorticoid treatment for checkpoint inhibitor-associated inflammatory arthritis does not affect cancer progression-free survival: a RADIOS Registry study
Cohort study
Rheumatology (Oxford)10 Apr 2026
Longitudinal incidence of native septic arthritis in France: a 13-year analysis of the National Health Data System Database
Cohort study
Arthritis Care Res (Hoboken)2 Apr 2026
Risk of Retinopathy Associated with Long‐Term Use of Hydroxychloroquine in Patients with Rheumatic Diseases: A Systematic Review and Meta‐Analysis
Meta-analysis
Lancet RheumatolApril 2026
Development of patient-initiated follow-up resources for UK rheumatology departments: a co-design study with patient and clinician collaboration
Research article
RMD Open19 Mar 2026
Cost-effectiveness of proactive therapeutic drug monitoring of maintenance infliximab treatment in patients with immune-mediated inflammatory diseases: results from a randomised controlled trial
Randomized controlled trial
Rheumatology (Oxford)15 Mar 2026
Vaccination rates in rheumatic diseases: a cross-sectional register study on the role of patient beliefs and physician engagement
Cross-sectional study
Semin Arthritis Rheum12 Mar 2026
Trends and outcomes of lung transplant listings for connective tissue disease-associated interstitial lung disease (CTD-ILD): A 20-Year analysis from the organ procurement and transplantation network database
Cohort study
Clin Exp Rheumatol10 Mar 2026
Sex and menopausal status differences in coronary calcification and extra-coronary computed tomography findings in inflammatory arthritis
Cross-sectional study
Arthritis Care Res (Hoboken)6 Mar 2026
Major US Formulary Change Triggers, but Does Not Sustain, Increases in Biosimilar Adalimumab Prescribing
Cohort study
Ann Rheum Dis5 Mar 2026
How long do people with rheumatic and musculoskeletal diseases stay healthy and in work across Europe? Analysis of data from SHARE and ELSA
Cohort study
Arthritis Res Ther5 Mar 2026
Development and validation of a risk score for serious infection in patients with rheumatic diseases receiving prolonged high-dose glucocorticoids
Diagnostic or prognostic study
RMD Open4 Mar 2026
CAR-T cell therapy for treatment-refractory rheumatic autoimmune diseases: a systematic review of clinical outcomes and safety profiles
Meta-analysis
Rheumatology (Oxford)27 Feb 2026
New phenotype and outcomes in connective tissue disease-associated pulmonary arterial hypertension: relevance of age-related comorbidities
Cohort study
Arthritis Rheumatol24 Feb 2026
Glucagon‐Like Peptide 1 Receptor Agonists, Sodium‐Glucose Cotransporter 2 Inhibitors, and Risk of Autoimmune Rheumatic Diseases
Cohort study
Arthritis Rheumatol17 Feb 2026
Impact of Early Antimalarial Adherence on Future Acute Care Utilization and Cost Among Patients With Rheumatoid Arthritis and Systemic Lupus Erythematosus: A Population‐Based Study
Cohort study
Arthritis Care Res (Hoboken)16 Feb 2026
Improving Access to Rheumatology Care: Evaluation of a Rheumatology Electronic Consultation Program
Research article
Joint Bone Spine10 Feb 2026
Factors associated with suicidal ideation among patients with inflammatory rheumatic and musculoskeletal diseases: A case-control study
Case-control study
Lancet Rheumatol9 Feb 2026
Recombinant herpes zoster vaccine in patients with autoimmune rheumatic diseases in Brazil: a double-blind, randomised, placebo-controlled, phase 4, non-inferiority study
Randomized controlled trial
Arthritis Care Res (Hoboken)6 Feb 2026
Retractions in Rheumatology: Trends, Causes, and Implications for Research Integrity
Cross-sectional study
Arthritis Care Res (Hoboken)6 Feb 2026
Utilization of Rehabilitation Services Among People With Common Autoimmune Rheumatic Diseases: A Systematic Review
Meta-analysis

All 474 Briefs in ExploreShowing Briefs 41–80 of 474, newest first